ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 59 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -25.0% | 13,500 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -50.0% | 13,500 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -42.9% | 13,500 | 0.0% | 0.00% | – |
| Q3 2021 | $14,000 | -26.3% | 13,500 | 0.0% | 0.00% | – |
| Q2 2021 | $19,000 | -17.4% | 13,500 | 0.0% | 0.00% | – |
| Q1 2021 | $23,000 | +35.3% | 13,500 | 0.0% | 0.00% | – |
| Q4 2020 | $17,000 | -10.5% | 13,500 | 0.0% | 0.00% | – |
| Q3 2020 | $19,000 | +18.8% | 13,500 | 0.0% | 0.00% | – |
| Q2 2020 | $16,000 | 0.0% | 13,500 | 0.0% | 0.00% | – |
| Q1 2020 | $16,000 | -52.9% | 13,500 | -15.6% | 0.00% | -100.0% |
| Q4 2019 | $34,000 | -67.0% | 16,000 | -66.0% | 0.00% | -50.0% |
| Q3 2019 | $103,000 | -13.4% | 47,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $119,000 | -27.4% | 47,000 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $164,000 | +50.5% | 47,000 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $109,000 | -58.1% | 47,000 | -30.4% | 0.00% | -60.0% |
| Q3 2018 | $260,000 | +20.9% | 67,500 | +6.3% | 0.01% | +25.0% |
| Q2 2018 | $215,000 | +61.7% | 63,500 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $133,000 | +3.1% | 63,500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $129,000 | -55.8% | 63,500 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $292,000 | +119.5% | 63,500 | +2.6% | 0.01% | +100.0% |
| Q2 2017 | $133,000 | -31.4% | 61,900 | 0.0% | 0.00% | -40.0% |
| Q1 2017 | $194,000 | +123.0% | 61,900 | +84.8% | 0.01% | +150.0% |
| Q4 2016 | $87,000 | -56.9% | 33,500 | -35.6% | 0.00% | -60.0% |
| Q3 2016 | $202,000 | +45.3% | 52,000 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $139,000 | -13.1% | 52,000 | 0.0% | 0.00% | -20.0% |
| Q1 2016 | $160,000 | -20.0% | 52,000 | 0.0% | 0.01% | -28.6% |
| Q4 2015 | $200,000 | +143.9% | 52,000 | +92.6% | 0.01% | +133.3% |
| Q3 2015 | $82,000 | -9.9% | 27,000 | +25.6% | 0.00% | 0.0% |
| Q2 2015 | $91,000 | +11.0% | 21,500 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $82,000 | -48.1% | 21,500 | -8.5% | 0.00% | -40.0% |
| Q4 2014 | $158,000 | +22.5% | 23,500 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $129,000 | -54.1% | 23,500 | -14.5% | 0.00% | -60.0% |
| Q2 2014 | $281,000 | -0.4% | 27,500 | +17.0% | 0.01% | 0.0% |
| Q1 2014 | $282,000 | +6.4% | 23,500 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $265,000 | – | 23,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |